Healthcare Policy
5 articles
Trump administration plan could weaken Medicare drug price negotiation
In 2024, Medicare spent $125 billion on just 40 drugs, representing over one-third (36%) of its total drug budget, according to KFF .
Drug companies ask FDA commissioner to pause new voucher program
Just months after its announcement, the FDA's Commissioner’s National Priority Voucher Program (CNPV), designed to slash drug approval times to as little as one month, is already facing calls from maj
HHS Finalizes Rule to Streamline No Surprises Act Provider Disputes
The U.S. Department of Health and Human Services (HHS) recently finalized a new rule. This rule aims to streamline how out-of-network payment disputes are resolved between healthcare providers and ins
Trump Drug Pricing Deals Face Test as New Drugs Launch
The Medicare negotiated price for semaglutide, the active ingredient in blockbuster drugs like Ozempic, is $274 under the Inflation Reduction Act.
Senate Democrats propose Medicare long-term care benefit
With the average annual cost of a nursing home exceeding $93,000 and Medicare covering almost none of it, Senate Democrats today proposed a new long-term care benefit, funded by a new payroll tax.